Statistics for Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG

Total visits

views
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG 325

Total visits per month

views
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 1
June 2024 4
July 2024 0

File Visits

views
Hadji_2017_management.pdf 281

Top country views

views
United States 211
Germany 59
United Kingdom 9
Ukraine 7
China 4
Russia 4
France 3
Canada 2
Switzerland 2
Italy 2
Netherlands 2
Austria 1
Hungary 1
Malaysia 1

Top city views

views
Wilmington 57
Gunzenhausen 31
Fairfield 25
Kiez 24
Houston 21
Ann Arbor 20
Cambridge 7
Jacksonville 7
Kansas City 7
Kiev 6
Washington 6
Sheffield 4
Beijing 3
Nürnberg 3
Saint Petersburg 3
San Francisco 3
Concord 2
Lake Mary 2
London 2
Roubaix 2
Toronto 2
Zoetermeer 2
Abingdon 1
Athens 1
Baltimore 1
Bremerton 1
Brooklyn 1
Caselle Torinese 1
Dearborn 1
Genova 1
Guangzhou 1
Irvine 1
Mountain View 1
Naszály 1
Netze 1
Paris 1
Philadelphia 1
Rotherham 1
Scottsdale 1
Seremban 1
Vienna 1
Vladimir 1